COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective

被引:10
作者
Cavaillon, Jean-Marc [1 ]
Osuchowski, Marcin F. [2 ]
机构
[1] French Natl Res Agcy ANR, F-75012 Paris, France
[2] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria
来源
JOURNAL OF INTENSIVE MEDICINE | 2021年 / 1卷 / 01期
关键词
Severe acute respiratory syndrome; coronavirus 2 (SARS-CoV-2); Coronavirus; Sepsis; Cytokines; Hydroxychloroquine; Vaccines; Pandemics; INFLAMMATORY RESPONSE; SEPTIC SHOCK; LUNG INJURY; I IFNS; DISEASE; RNA; VECTOR; HYDROXYCHLOROQUINE; METAANALYSIS; ANTIBODIES;
D O I
10.1016/j.jointm.2021.04.003
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Humanity has regularly faced the threat of epidemics and pandemics over the course of history. Successful attempts to protect populations were initially made with the development of new vaccines, such as those against plague and cholera, under the leadership of the bacteriologist Waldemar Haffkine. Vaccines have led to a complete eradication of smallpox and bovine plague and a major reduction in other infectious diseases including diphtheria, typhoid fever, poliomyelitis, and Haemophilus influenzae type B meningitis. While a few coronaviruses have been identified that seasonally infect humans causing mild symptoms, the emergence of a new zoonotic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly triggered the ongoing coronavirus disease 2019 (COVID-19) as a global pandemic responsible for widespread mortality. The severe phenotypes of COVID-19 resemble a previous infectious threat that was initially designated as hospital fever and puerperal fever, presently known as sepsis. A SARS-CoV-2 infection has frequently been considered as a form of viral sepsis (owing to common features with bacterial sepsis) but is also associated with an array of specific and unique symptoms. Rapid progress in anti-SARS-CoV-2 vaccine development, in particular, the design of efficient messenger RNA (mRNA) and recombinant adenovirus vaccines, is crucial for curbing the pandemic.
引用
收藏
页码:4 / 13
页数:10
相关论文
共 118 条
[61]   The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy [J].
Lin, Hong-Yuan .
CHINESE JOURNAL OF TRAUMATOLOGY, 2020, 23 (04) :190-195
[62]   Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study [J].
Liu, Sean T. H. ;
Lin, Hung-Mo ;
Baine, Ian ;
Wajnberg, Ania ;
Gumprecht, Jeffrey P. ;
Rahman, Farah ;
Rodriguez, Denise ;
Tandon, Pranai ;
Bassily-Marcus, Adel ;
Bander, Jeffrey ;
Sanky, Charles ;
Dupper, Amy ;
Zheng, Allen ;
Nguyen, Freddy T. ;
Amanat, Fatima ;
Stadlbauer, Daniel ;
Altman, Deena R. ;
Chen, Benjamin K. ;
Krammer, Florian ;
Mendu, Damodara Rao ;
Firpo-Betancourt, Adolfo ;
Levin, Matthew A. ;
Bagiella, Emilia ;
Casadevall, Arturo ;
Cordon-Cardo, Carlos ;
Jhang, Jeffrey S. ;
Arinsburg, Suzanne A. ;
Reich, David L. ;
Aberg, Judith A. ;
Bouvier, Nicole M. .
NATURE MEDICINE, 2020, 26 (11) :1708-+
[63]   COVID-19: Progress in diagnostics, therapy and vaccination [J].
Liu, Xue ;
Liu, Chao ;
Liu, Gang ;
Luo, Wenxin ;
Xia, Ningshao .
THERANOSTICS, 2020, 10 (17) :7821-7835
[64]   Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia [J].
Logunov, Denis Y. ;
Dolzhikova, Inna V. ;
Shcheblyakov, Dmitry V. ;
Tukhvatulin, Amir I. ;
Zubkova, Olga V. ;
Dzharullaeva, Alina S. ;
Kovyrshina, Anna V. ;
Lubenets, Nadezhda L. ;
Grousova, Daria M. ;
Erokhova, Alina S. ;
Botikov, Andrei G. ;
Izhaeva, Fatima M. ;
Popova, Olga ;
Ozharovskaya, Tatiana A. ;
Esmagambetov, Ilias B. ;
Favorskaya, Irina A. ;
Zrelkin, Denis I. ;
Voronina, Daria V. ;
Shcherbinin, Dmitry N. ;
Semikhin, Alexander S. ;
Simakova, Yana V. ;
Tokarskaya, Elizaveta A. ;
Egorova, Daria A. ;
Shmarov, Maksim M. ;
Nikitenko, Natalia A. ;
Gushchin, Vladimir A. ;
Smolyarchuk, Elena A. ;
Zyryanov, Sergey K. ;
Borisevich, Sergei V. ;
Naroditsky, Boris S. ;
Gintsburg, Alexander L. .
LANCET, 2021, 397 (10275) :671-681
[65]   Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks? [J].
Machiels, Julian D. ;
Bleeker-Rovers, Chantal P. ;
ter Heine, Rob ;
Rahamat-Langendoen, Janette ;
de Mast, Quirijn ;
ten Oever, Jaap ;
Bousema, Teun ;
van Crevel, Reinout ;
Wertheim, Heiman F. L. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (01)
[66]   Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant [J].
Madhi, S. A. ;
Baillie, V ;
Cutland, C. L. ;
Voysey, M. ;
Koen, A. L. ;
Fairlie, L. ;
Padayachee, S. D. ;
Dheda, K. ;
Barnabas, S. L. ;
Bhorat, Q. E. ;
Briner, C. ;
Kwatra, G. ;
Ahmed, K. ;
Aley, P. ;
Bhikha, S. ;
Bhiman, J. N. ;
Bhorat, A' E. ;
du Plessis, J. ;
Esmail, A. ;
Groenewald, M. ;
Horne, E. ;
Hwa, S-H ;
Jose, A. ;
Lambe, T. ;
Laubscher, M. ;
Malahleha, M. ;
Masenya, M. ;
Masilela, M. ;
McKenzie, S. ;
Molapo, K. ;
Moultrie, A. ;
Oelofse, S. ;
Patel, F. ;
Pillay, S. ;
Rhead, S. ;
Rodel, H. ;
Rossouw, L. ;
Taoushanis, C. ;
Tegally, H. ;
Thombrayil, A. ;
van Eck, S. ;
Wibmer, C. K. ;
Durham, N. M. ;
Kelly, E. J. ;
Villafana, T. L. ;
Gilbert, S. ;
Pollard, A. J. ;
de Oliveira, T. ;
Moore, P. L. ;
Sigal, A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (20) :1885-1898
[67]   INDUCTION OF VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN-VIVO BY LIPOSOME-ENTRAPPED MESSENGER-RNA [J].
MARTINON, F ;
KRISHNAN, S ;
LENZEN, G ;
MAGNE, R ;
GOMARD, E ;
GUILLET, JG ;
LEVY, JP ;
MEULIEN, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (07) :1719-1722
[68]   Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques [J].
Mercado, Noe B. ;
Zahn, Roland ;
Wegmann, Frank ;
Loos, Carolin ;
Chandrashekar, Abishek ;
Yu, Jingyou ;
Liu, Jinyan ;
Peter, Lauren ;
McMahan, Katherine ;
Tostanoski, Lisa H. ;
He, Xuan ;
Martinez, David R. ;
Rutten, Lucy ;
Bos, Rinke ;
van Manen, Danielle ;
Vellinga, Jort ;
Custers, Jerome ;
Langedijk, Johannes P. ;
Kwaks, Ted ;
Bakkers, Mark J. G. ;
Zuijdgeest, David ;
Rosendahl Huber, Sietske K. ;
Atyeo, Caroline ;
Fischinger, Stephanie ;
Burke, John S. ;
Feldman, Jared ;
Hauser, Blake M. ;
Caradonna, Timothy M. ;
Bondzie, Esther A. ;
Dagotto, Gabriel ;
Gebre, Makda S. ;
Hoffman, Emily ;
Jacob-Dolan, Catherine ;
Kirilova, Marinela ;
Li, Zhenfeng ;
Lin, Zijin ;
Mahrokhian, Shant H. ;
Maxfield, Lori F. ;
Nampanya, Felix ;
Nityanandam, Ramya ;
Nkolola, Joseph P. ;
Patel, Shivani ;
Ventura, John D. ;
Verrington, Kaylee ;
Wan, Huahua ;
Pessaint, Laurent ;
Van Ry, Alex ;
Blade, Kelvin ;
Strasbaugh, Amanda ;
Cabus, Mehtap .
NATURE, 2020, 586 (7830) :583-+
[69]   The anti-inflammatory response dominates after septic shock:: association of low monocyte HLA-DR expression and high interleukin-10 concentration [J].
Monneret, G ;
Finck, ME ;
Venet, F ;
Debard, AL ;
Bohé, J ;
Bienvenu, J ;
Lepape, A .
IMMUNOLOGY LETTERS, 2004, 95 (02) :193-198
[70]   Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain [J].
Montero-Escribano, Paloma ;
Matias-Guiu, Jorge ;
Gomez-Iglesias, Patricia ;
Porta-Etessam, Jesus ;
Pytel, Vanesa ;
Matias-Guiu, Jordi A. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42